Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Big platelets in hyperlipidemic patients.

J Fuchs1, Y Beigel, P Green

  • 1Department of Internal Medicine A, Beilinson Medical Center, Petah-Tiqva, Israel.

Journal of Clinical Pharmacology
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bouldering-related trauma: Injury patterns and operative burden over 10 years at a UK major trauma centre.

Injury·2026
Same author

Prevalence of adverse events and their effect on completion of high speed treadmill exercise tests at a single institution (2000-2015).

Equine veterinary journal·2019
Same author

Developing culturally adapted lifestyle interventions for South Asian migrant populations: a qualitative study of the key success factors and main challenges.

Public health·2018
Same author

The age of fine-root carbon in three forests of the eastern United States measured by radiocarbon.

Oecologia·2017
Same author

An equivalence study: Are patient-completed and telephone interview equivalent modes of administration for the EuroQol survey?

Health and quality of life outcomes·2017
Same author

The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up.

Journal of cancer research and clinical oncology·2015
Same journal

FDA Gene Therapy Approvals (1998-2025): Current Status, Regulatory Evolution, and Future Directions.

Journal of clinical pharmacology·2026
Same journal

Human Disposition, Metabolism, and Excretion of Sevasemten (EDG-5506), a Selective Modulator of Fast Myosin in Healthy Volunteers.

Journal of clinical pharmacology·2026
Same journal

New Insights into Genetic Polymorphisms Influencing the Therapeutic Efficacy and Toxicity of Rivaroxaban.

Journal of clinical pharmacology·2026
Same journal

Physiologically Based Pharmacokinetic Modeling to Predict the Pharmacokinetics of Sacubitril/Valsartan in the Elderly with Renal or Hepatic Impairment Population.

Journal of clinical pharmacology·2026
Same journal

The Journal of Clinical Pharmacology: 65 Years of History.

Journal of clinical pharmacology·2026
Same journal

Decoupling CAR-T Expansion, Conversion, and Decay Timing: Physiologically Aligned Semi-Mechanistic Modeling With Smooth Gating and a Cauchy Likelihood Residual Model.

Journal of clinical pharmacology·2026
See all related articles

This study investigated hypolipidemic drugs' effects on big platelets in hyperlipidemia patients. Results showed no significant change in big platelet percentage despite lipid level improvements, questioning the direct relationship.

Area of Science:

  • Cardiology
  • Hematology
  • Pharmacology

Background:

  • Large platelets and hyperlipidemia are linked to increased coronary artery disease risk.
  • The potential impact of lipid-lowering medications on platelet size remains unclear.

Purpose of the Study:

  • To investigate the effect of hypolipidemic drugs on the percentage of big platelets in patients with hyperlipidemia.
  • To explore the relationship between lipid reduction and big platelet levels.

Main Methods:

  • Microscopic assessment of big platelet percentage in 66 hyperlipidemia patients.
  • A crossover study using fish oil or placebo for hypertriglyceridemia patients.
  • Lovastatin treatment for hypercholesterolemia patients, including those with familial hypercholesterolemia.

Related Experiment Videos

Main Results:

  • Pre-treatment big platelet levels were elevated and similar across all groups.
  • No significant change in big platelet percentage was observed after treatment with fish oil or lovastatin.
  • Lipoprotein profiles improved, but big platelet levels remained unchanged.

Conclusions:

  • The direct relationship between lipid reduction and big platelet levels is questionable.
  • Further research is needed to understand the complex interplay between lipids and platelet characteristics.